Written and maintained by CASRAI Editorial Board
Last updated
What the Human Pathogens and Toxins Act does
The Human Pathogens and Toxins Act (HPTA, S.C. 2009, c. 24) is Canada’s federal statute governing the possession, handling, and controlled activities involving human pathogens and toxins. It is Canada’s counterpart to the biosafety-and-biosecurity oversight structure that, in the United States, is split across the Federal Select Agent Program and the DURC policy — a single Canadian institution working with regulated biological material needs to satisfy the HPTA and its accompanying Human Pathogens and Toxins Regulations (HPTR), rather than the layered US framework, but the underlying compliance questions a research administrator has to answer are the same shape: what is regulated, who needs a licence, what security clearances are required, and who has to be told before work starts.
The Act works together with its regulations (SOR/2015-44): the HPTA sets the legal framework — licensing, offences, and ministerial powers — while the HPTR fills in the operational detail, including the biosafety and biosecurity standards a licensed facility must actually meet. The Public Health Agency of Canada (PHAC) is the federal body responsible for administering and enforcing the HPTA/HPTR day to day — issuing licences, setting biosafety-standard guidance, and inspecting licensed facilities — functionally the closest Canadian equivalent to the CDC’s role in administering the US Federal Select Agent Program.
What is regulated
The HPTA regulates “human pathogens and toxins” through a schedule-based system: the Act’s schedules list specific pathogens and toxins subject to control, and a licence is required to carry out controlled activities involving them — this includes possessing, handling, or otherwise working with a listed pathogen or toxin, not only importing or transporting it. Controlled activities are defined broadly enough to cover most standard laboratory work with a listed agent, not just novel or higher-risk manipulations of it.
Section 12 of the Act creates a duty to inform the federal government of relevant activities — institutions working with regulated material do not simply register once and continue silently; ongoing activity involving a listed pathogen or toxin has to be disclosed to the Minister as it occurs, not just at initial licensing.
Licensing and facility requirements
Section 18 of the Act sets out the licensing regime: an institution intending to carry out a controlled activity with a regulated human pathogen or toxin must hold a licence for that activity. Sections 31 through 36 then set out the facility-level obligations that attach to holding one, including:
- Access controls restricting who can physically enter a licensed facility or area where regulated material is kept.
- Security clearance requirements for personnel working with the material, comparable in function to the personnel-reliability checks the US Select Agent Program requires of an entity’s Responsible Official and other approved individuals.
- A designated Biological Safety Officer, responsible for biosafety and biosecurity oversight at the licensed facility — functionally the Canadian equivalent of the biosafety-officer role every Institutional Biosafety Committee structure in the US relies on.
- A Licence Holder Representative, a role added to the framework by later amendments to the Act, giving a named individual authority to act on the licence holder’s behalf for regulatory purposes.
Violations of the Act’s requirements carry criminal penalties under section 53 — this is not a civil or purely administrative compliance regime; failure to hold a required licence, or breach of the conditions attached to one, is an offence under Canadian federal law.
Risk groups: the same underlying concept as BSL, applied to Canadian regulation
Like the US biosafety framework, Canadian biosafety practice classifies biological agents into Risk Groups reflecting the hazard an agent poses, distinct from (though correlated with) the physical containment level — Biosafety Level — a facility must provide to work with it safely. This Risk-Group-versus-containment-level distinction is a general biosafety principle, not specific to either country’s regulatory text: an agent’s Risk Group is a property of the agent itself, while the Biosafety Level is a property of the facility and practices used to handle it, and the two do not map one-to-one in every case. A Canadian institution licensed under the HPTA still has to run its own facility-specific risk assessment for a given protocol, the same discipline CASRAI’s existing BSL and biosafety-committee content already covers for a US audience.
Who it applies to
The HPTA applies to any person or organization in Canada carrying out a controlled activity involving a listed human pathogen or toxin — in practice, this means universities, research hospitals, government and private laboratories, and any other institution whose research or diagnostic work involves regulated biological material. A Canadian research administrator’s practical role is usually coordinating the institutional licence application, tracking which specific pathogens/toxins on the schedules are actually in use across the institution’s labs, and making sure the required Biological Safety Officer and security-clearance obligations are met before work with a newly acquired regulated agent begins — not after.
How it compares to the US framework
| Canada — HPTA/HPTR | United States — Federal Select Agent Program | |
|---|---|---|
| Core instrument | Human Pathogens and Toxins Act (S.C. 2009, c. 24) + HPTR (SOR/2015-44) | Select Agent Regulations (42 CFR 73 / 7 CFR 331 / 9 CFR 121) |
| Regulated list | Pathogens and toxins listed in the Act’s schedules | Select Agent List |
| Registration/licence | Institutional licence per controlled activity (s. 18) | Entity registration with a named Responsible Official |
| Facility safety officer | Designated Biological Safety Officer (s. 33) | Institutional Biosafety Committee oversight |
| Personnel screening | Security clearance requirement | Security Risk Assessment via the FBI |
| Enforcement basis | Criminal offence under s. 53 | Civil and criminal penalties under the Select Agent Regulations |
The two frameworks are not interchangeable and neither substitutes for the other — an institution with cross-border collaborations or shipments involving regulated material needs to satisfy both regimes independently for its own jurisdiction, and shipping a regulated agent across the Canada–US border triggers import/export controls on both sides, not just one.
Frequently asked questions
What federal department oversees the Human Pathogens and Toxins Act?
The Public Health Agency of Canada (PHAC) administers and enforces the HPTA and its regulations — issuing licences, setting biosafety-standard guidance, and inspecting licensed facilities. The underlying Act itself is Government of Canada federal legislation (S.C. 2009, c. 24).
Does the HPTA apply to a lab that only works with non-listed organisms?
No. The Act’s controlled-activity requirements attach specifically to the pathogens and toxins listed in its schedules. Work with an unlisted organism is not subject to the Act’s licensing regime, though it may still fall under other biosafety or institutional oversight requirements.
Is a Canadian HPTA licence the same as a US Select Agent registration?
No. They are separate national regulatory regimes with separate lists, separate licensing/registration processes, and separate enforcing authorities. An institution operating in both countries, or shipping regulated material across the border, must satisfy both independently.
What triggers the duty to inform the Minister under section 12?
Section 12 creates an ongoing obligation to disclose relevant controlled activities to the federal government, not a one-time registration step — consult the Act’s current text and its regulations for the specific triggering events and timelines that apply to a given activity.
This page covers Canada’s federal biosafety/biosecurity statute. For the equivalent US compliance landscape, see CASRAI’s guide to the Federal Select Agent Program and DURC oversight, and the Select Agent List and Biosafety Level dictionary entries.
